Search
for
Sort by
Research 30 of 1000+
- Hepatitis C virus: host, environmental and viral factors promoting spontaneous clearance
- Skin diseases associated with hepatitis C virus: Facts and controversies
- Gender-specific alteration of steroid metabolism and its impact on viral replication in a mouse model of hepatitis B virus infection
- Lichen Planus Pigmentosus as a Cutaneous Extrahepatic Manifestation of Chronic Hepatitis C Virus Infection: A Case Report
- Alopecia areata after hepatitis C virus infection treatment: a case report
- Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area
- Quantitation of Hepatitis C Virus RNA
- Betulinic acid exerts anti‐hepatitis C virus activity via the suppression of NF‐κB‐ and MAPK‐ERK1/2‐mediated COX‐2 expression
- Irreversible alopecia universalis during treatment with pegylated interferon-ribavirin for chronic hepatitis C virus infection: Case report and published work review
- Bullous Lesions at Polyethylene Glycol Interferon-alpha-2a Inoculation Site in a Hepatitis C Virus-infected Subject
- Reversible alopecia universalis secondary to PEG-interferon ??-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection
- Assessment of Dermatological Disorders with Chronic Hepatitis C Virus Infection
- Microscopic anatomy of the skin of the woodchuck (Marmota monax): comparison of woodchuck hepatitis virus-infected and non-infected animals.
- JAK Inhibitor Therapy in Alopecia Areata with Latent Hepatitis B Virus or Tuberculosis Infection: A Safety Assessment
- JAK Inhibitor Therapy in Alopecia Areata with Latent Hepatitis B Virus or Tuberculosis Infection: A Safety Assessment
- Molecular Mechanism of Avicennia marina (Forssk.) Vierh. in Inhibiting Hepatitis C Virus Based on Network Pharmacology and Molecular Docking
- Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon α 2a therapy for chronic hepatitis C virus infection
- Erosive Lichen Planus of the Scalp and Hepatitis C Infection
- Sa1389: LESSONS FROM HEPATITIS C TREATMENT DURING THE COVID-19 PANDEMIC: DECREASED RESOURCE UTILIZATION LEADS TO SIMILAR EFFICACY IN BRITISH COLUMBIA, CANADA
- Relapsing Hepatitis A: An Asymptomatic Recurrence of Elevated Liver Chemistries
- Evaluation of the Relationship between Alopecia Areata and Viral Antigen Exposure
- Cutaneous and Mucosal Lichen Planus: A Comprehensive Review of Clinical Subtypes, Risk Factors, Diagnosis, and Prognosis
- Familial and Sporadic Porphyria Cutanea Tarda
- An epidemic of porphyria cutanea tarda?
- Clinico-Epidemiological Aspects of Cutaneous Lesions in Injecting Drug Users Visiting an Oral Substitution Therapy Centre: A Cross-Sectional Study
- Hepatitis C‐related mixed type vitiligo in a patient with Ivemark syndrome
- Drug-induced postinfantile giant cell hepatitis
- Segmental Vitiligo and Hair Curling After Interferon α and Ribavirin Treatment for Hepatitis C
- Vaccines, Infections, and Alopecia Areata
- Exacerbation of alopecia areata during pegylated interferon alpha-2b and ribavirin therapy, possibly due to the collapse of hair follicle immune privilege